Company Overview and News

to your dashboard

Headline News

Benitec Biopharma (BTEBY) Presents At 10th Annual Biotech Showcase 2018 - Slideshow

2018-01-09 seekingalpha
The following slide deck was published by Benitec Biopharma Ltd ADR in conjunction with this event.

Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition

2017-11-30 seekingalpha
We discuss Bausch and Lomb’s India sales, and whether that has any bearing on Valeant’s woes. (486-1)

Benitec Biopharma’s shares ride higher after securing new U.S. patent

Benitec Biopharma Ltd’s (ASX:BLT) shares closed 20% higher on Wednesday after securing a new patent related to its hepatitis B program in the U.S.

Technical Reports on Biotech Equities -- BioDelivery Sciences, BioLine Rx, Benitec Biopharma, and Soligenix

2017-08-01 prnewswire
If you want a Stock Review on BDSI, BLRX, BNTC or SNGX then come over to and sign up for your free customized report today. has initiated coverage on BioDelivery Sciences International Inc. (NASDAQ: BDSI), BioLine Rx Ltd (NASDAQ: BLRX), Benitec Biopharma Ltd (NASDAQ: BNTC), and Soligenix Inc. (NASDAQ: SNGX). These equities operate in the Biotech space, which consists of companies engaged in the research and development of new drugs, medical devices, and procedures.

The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

2017-07-19 marketwired
WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017. (0-1)

Benitec Biopharma's (BNIKF) CEO Greg West on Q1 2017 Results - Earnings Call Transcript

2017-05-31 seekingalpha
Thank you for standing by and welcome to the Benitec Biopharma Quarterly Corporate Update Conference Call.

How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

2017-04-26 prnewswire
On Tuesday, April 25, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, assessed the following Biotechnology equities this morning: Cymabay Therapeutics Inc. (NASDAQ: CBAY), Benitec Biopharma Ltd (NASDAQ: BNTC), Sage Therapeutics Inc.

Research Reports Initiation on Banking Stocks -- Comerica, Home Bancshares, Bank of Montreal, and Canadian Imperial Bank of Commerce

2017-04-26 prnewswire
On Tuesday, April 25, 2017, US markets saw broad based gains with eight out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday's session. The NASDAQ Composite ended the day at 6,025.49, up 0.70%; the Dow Jones Industrial Average edged 1.12% higher, to finish at 20,996.12; and the S&P 500 closed at 2,388.61, up 0.61%. This Wednesday morning, Stock-Callers.

Appointment of Chairman

2017-04-20 londonstockexchange
Redx Pharma, the research and development company focused on cancer, immunology and infection, announces that it has appointed Mr Iain Ross as Chairman of its Board of Directors and as a Non-Executive Director of the Company, effective from 1st May 2017.

Here's Why Benitec Biopharma Stock Soared 79.7% Higher This Morning

2017-04-04 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

BRIEF-Hydropothecary Corp reports Q2 net loss per share $ 0.13

2017-04-04 reuters
LONDON, April 4 Global investment banking fees reached a 10-year high in the first quarter of 2017 with more than half of the $24 billion in total takings coming from North America, Thomson Reuters data showed on Tuesday.

BRIEF-Solar Alliance signs letter of intent to acquire U.S. solar assets

2017-04-04 reuters
* Solar Alliance Energy - as per loi, co will acquire seller's team of employees and acquire seller's pipeline of in-process residential solar projects

BRIEF-Benitec Biopharma says key pre-clinical data on muscular dystrophy published in nature communications

2017-04-04 reuters
* Benitec Biopharma Ltd - key pre-clinical data on oculopharyngeal muscular dystrophy (opmd) published in nature communications

Benitec Biopharma receives $5.59M to advance gene silencing tech

Benitec Biopharma (ASX:BLT) has received a $5.59 million cash refund under the Federal Government’s R&D Tax Incentive Scheme.

Benitec Biopharma tops ASX % Gainers intra-day

Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.